eTect is a developer of ingestible sensor technology for medication adherence.  The principals of Pelagic Group co-founded eTect and grew it from a research experiment to one of the leading medication adherence technology companies in the world. Pelagic Group was instrumental in defining and executing the company strategy, building the executive and development teams, securing investment and building strategic relationships with global partners in the pharmaceutical, payer, and healthcare ecosystems.